In Finland, Kemira and IFF announced that they have taken the final investment decision and move forward in forming a joint venture manufacturing company to produce renewable biobased products on a commercial scale
Commercial production is expected to start in late 2027. Both companies will have a 50% stake in the joint venture. Kemira and IFF have been collaborating in a strategic partnership since 2020.
The new manufacturing plant will be located at IFF Biorefinery in Kotka, Finland to leverage available synergies and infrastructure as well as European biobased raw materials. The facility will convert up to 44,000 MT of plant sugars to bioproducts, including sustainable, high-performance biopolymers for use in various applications and will be a platform material for further processing to make new renewable products.
The plant is designed to produce multiple grades of DEB biomaterial to accommodate various market applications, Kemira said.
More on the story.
